Health Trials

Neuroendocrine Prostate Cancer

2

Review clinical trials related to Neuroendocrine Prostate Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[225Ac\]Ac-ETN029 and the safety and imaging properties of \[111In\]In-ETN029 in patients aged ≥ 18 years with locally advanced or metastatic DLL3 positive cancers.

Participants needed: 116
Trial details
Phase: Phase 1Age: 18-100Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: May 5, 2026Locations: 6
Eligibility criteria

Age ≥ 18 years old [+4]

Absolute neutrophil count (ANC) < 1.0 x 109/L, hemoglobin < 9 g/dL, or platelet... [+6]

Read more
Status: Not yet recruiting

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

This is a multicenter, open-label Phase II study, aimed at exploring the preliminary efficacy and safety of ZG006 in patients with advanced metastatic NEPC who have previously failed standard treatment.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-80Biological sex: MaleType: InterventionalSponsor: Suzhou Zelgen Biopharmaceuticals Co.,LtdUpdated: Jun 17, 2025Locations: 1
Eligibility criteria

Male Participants aged 18 to 80 years (inclusive); [+4]

Known positive test for human immunodeficiency virus (HIV) or hepatitis； [+1]

Read more